First treatment licensed for primary progressive MS in the US

Posted March 30th, 2017 by Sue & filed under MS News.

Source MS Society:

Ocrelizumab has been approved as a treatment for both relapsing and primary progressive MS in the US. https://www.mssociety.org.uk/ms-news/2017/03/first-treatment-licensed-primary-progressive-ms-us